In vitro qRT-PCR validation in bladder cancer cell lines showed downregulation of LIMS2, IRAK3, STX2, IL11RA, KCNMB1, and PDLIM7, consistent with bioinformatics findings, suggesting that these genes may serve as potential therapeutic targets. This evidence concerns the gene LIMS2 and urinary bladder carcinoma.